Hiurma Perez-Sanchez

Santa Cruz De Tenerife, CN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Amylin serum levels are upregulated in patients with systemic lupus erythematosus.

Amylin serum levels are upregulated in patients with systemic lupus erythematosus.

Journal: Clinical and experimental rheumatology

Published: July 02, 2021

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus.

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus.

Journal: Therapeutic advances in musculoskeletal disease

Published: August 20, 2020

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis.

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis.

Journal: Arthritis research & therapy

Published: August 20, 2020

Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus.

Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus.

Journal: The Journal of rheumatology

Published: June 04, 2020

Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Journal: Arthritis care & research

Published: April 21, 2020

Impact of Disease Activity on Physical Activity in Patients With Psoriatic Arthritis.

Impact of Disease Activity on Physical Activity in Patients With Psoriatic Arthritis.

Journal: Arthritis care & research

Published: February 04, 2020

HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients.

HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients.

Journal: Clinical rheumatology

Published: December 14, 2019

Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis.

Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis.

Journal: Clinical and experimental rheumatology

Published: December 03, 2019

Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Journal: Clinical and experimental rheumatology

Published: August 09, 2019

Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis.

Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis.

Journal: Rheumatology (Oxford, England)

Published: July 19, 2019

Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment.

Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment.

Journal: Reumatologia clinica

Published: October 04, 2018

Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.

Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.

Journal: The Journal of rheumatology

Published: September 21, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026